Friday, July 10, 2026

pharma · Glaucoma · Macular Edema

Allergan Pharmaceuticals International

Allergan Pharmaceuticals International is a pharma organization headquartered in Dublin, IE. Primary therapeutic focus areas include Glaucoma, Macular Edema, Macular Degeneration, Dry Eye Syndromes, Choroid Neovasculariz

Dublin, IE HQ
EMA registrant Type
Company details
Clinical program

botulinum toxin type A

Phase 2 · mab · Cervical Dystonia

botulinum toxin type A for Cervical Dystonia is a Phase 2 program (mab) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).

Internal code 191622-090

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Allergan Pharmaceuticals International Limited
Phase
Phase 2
Modality
mab
Indication
Cervical Dystonia
Status
completed
Trials
1